Join
Live feed
·
PRReleasevia Quantisnow
OS Therapies Incorporated logo

OS Therapies Files New Patent Application Covering Biomarkers of the Immune Response to Listeria Monocytogenes

ByQuantisnow·Wall Street's wire, on your screen.
OSTX· OS Therapies Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OSTX (OS Therapies Incorporated) and more on Quantisnow.